X-64917805-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PVS1_StrongBS2

The NM_001178033.3(ZC4H2):​c.490C>T​(p.Arg164*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,209,068 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.0000018 ( 0 hom. 0 hem. )

Consequence

ZC4H2
NM_001178033.3 stop_gained

Scores

6
7
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 9.22
Variant links:
Genes affected
ZC4H2 (HGNC:24931): (zinc finger C4H2-type containing) This gene encodes a member of the zinc finger domain-containing protein family. This family member has a C-terminal zinc finger domain that is characterized by four cysteine residues and two histidine residues, and it also includes a coiled-coil region. This protein has been detected as an autoantigen in hepatocellular carcinoma patients. This gene has been identified as a potential candidate for X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region.
BS2
High Hemizygotes in GnomAd4 at 2 XLR,XLD,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZC4H2NM_018684.4 linkc.653C>T p.Pro218Leu missense_variant Exon 5 of 5 ENST00000374839.8 NP_061154.1 Q9NQZ6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZC4H2ENST00000374839.8 linkc.653C>T p.Pro218Leu missense_variant Exon 5 of 5 1 NM_018684.4 ENSP00000363972.3 Q9NQZ6-1

Frequencies

GnomAD3 genomes
AF:
0.0000359
AC:
4
AN:
111478
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000978
Gnomad AMI
AF:
0.00146
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000552
AC:
1
AN:
181319
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000124
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000182
AC:
2
AN:
1097590
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
362972
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26392
American (AMR)
AF:
0.00
AC:
0
AN:
35161
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19378
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53958
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40486
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4118
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841853
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.600
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000359
AC:
4
AN:
111478
Hom.:
0
Cov.:
23
AF XY:
0.0000594
AC XY:
2
AN XY:
33668
show subpopulations
African (AFR)
AF:
0.0000978
AC:
3
AN:
30673
American (AMR)
AF:
0.00
AC:
0
AN:
10461
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2636
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3547
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2621
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6018
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53096
Other (OTH)
AF:
0.00
AC:
0
AN:
1503
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Oct 27, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.653C>T (p.P218L) alteration is located in exon 5 (coding exon 5) of the ZC4H2 gene. This alteration results from a C to T substitution at nucleotide position 653, causing the proline (P) at amino acid position 218 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Aug 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 218 of the ZC4H2 protein (p.Pro218Leu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ZC4H2-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Uncertain
0.080
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.79
D;.
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D;D
MetaRNN
Uncertain
0.70
D;D
MetaSVM
Benign
-0.50
T
PhyloP100
9.2
PrimateAI
Pathogenic
0.86
D
PROVEAN
Pathogenic
-6.8
D;D
REVEL
Uncertain
0.45
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.0040
D;T
Polyphen
1.0
D;.
Vest4
0.68
MutPred
0.49
Gain of helix (P = 0.0022);.;
MVP
0.71
MPC
3.1
ClinPred
0.98
D
GERP RS
5.4
Varity_R
0.79
gMVP
0.81
Mutation Taster
=42/158
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs758832940; hg19: chrX-64137685; COSMIC: COSV62002567; COSMIC: COSV62002567; API